FDA Inspection 1254435 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Oct 31, 2024 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 31, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Orleans, LA (United States)